Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance

Circulation

Volumn 101, Issue 25, 2000, Pages 2916-2921

  Harbarth, Stephan ^a,e   Samore, Matthew H ^b,d   Lichtenberg, Debi ^b   Carmeli, Yehuda ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF UTAH HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antibiotics; Bypass; Infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTRIAXONE; CEPHALOSPORIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSE; PRIORITY JOURNAL; PROPHYLAXIS; SURGICAL INFECTION;

EID: 0034720840     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.25.2916     Document Type: Article

References (28)

1. Finland M. Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis. 1970;122:419-431.
2. Nelson RM, Dries DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg. 1986;42:240-246.
3. Milano CA, Kesler K, Archibald N, et al. Mediastinitis after coronary artery bypass graft surgery: risk factors and long-term survival. Circulation. 1995;92:2245-2251.
4. Hall RE, Ash AS, Ghali WA, et al. Hospital cost of complications associated with coronary artery bypass graft surgery. Am J Cardiol. 1997;79:1680-1682.
5. Goldmann DA, Hopkins CC, Karchmer AW, et al. Cephalothin prophylaxis in cardiac valve surgery: a prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg. 1977;73: 470-479.
6. Nooyen SM, Overbeek BP, Brutel de la Riviere A, et al. Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting. Eur J Clin Microbiol Infect Dis. 1994;13:1033-1037.
7. Niederhäuser U, Vogt M, Vogt P, et al. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg. 1997;114:162-168.
8. Kriaras I, Michalopoulos A, Michalis A, et al. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg. 1997;38:605-610.
9. Ariano RE, Zhanel GG. Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal. DICP Ann Pharmacother. 1991;25:478-484.
10. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations: meta-analysis of 30 years of clinical trials. J Thorac Cardiovasc Surg. 1992;104:590-599.
11. Kappstein I, Daschner FD. Use of perioperative antibiotic prophylaxis in selected surgical procedures: results of a survey in 889 surgical departments in German hospitals. Infection. 1991;19:391-394.
12. Parry GW, Holden SR, Shabbo FP. Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice. Br Heart J. 1993;70:585-586.
13. Lee KR, Ring JC, Leggiadro RJ. Prophylactic antibiotic use in pediatric cardiovascular surgery: a survey of current practice. Pediatr Infect Dis J. 1995;14:267-269.
14. Martin C, Pourriat JL. Quality of perioperative antibiotic administration by French anaesthetists. J Hosp Infect. 1998;40:47-53.
15. Namias N, Harvill S, Ball S, et al. Cost and morbidity associated with antibiotic prophylaxis in the ICU. J Am Coll Surg. 1999;188:225-230.
16. Kreisel D, Savel TG, Silver AL, et al. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg. 1995;130:989-993.
17. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13: 606-608.
18. Samore M, Lichtenberg D, Saubermann L, et al. A clinical data repository enhances hospital infection control. Proc AMIA Annu Fall Symp. 1997; 56-60.
19. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281-286.
20. Krieger JN, Kaiser DL, Wenzel RP. Nosocomial urinary tract infections cause wound infections postoperatively in surgical patients. Surg Gynecol Obstet. 1983;156:313-318.
21. Demetriades D, Breckon V, Breckon C, et al. Antibiotic prophylaxis in penetrating injuries of the chest. Ann R Coll Surg Engl. 1991;73: 348-351.
22. McDonald M, Grabsch E, Marshall C, et al. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998;68:388-396.
23. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis. 1983;147: 642-649.
24. Kernodle DS, Barg NL, Kaiser AB. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother. 1988;32:202-208.
25. Terpstra S, Noordhoek GT, Voesten HG, et al. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect. 1999;43:195-202.
26. Ehrenkranz NJ. Antimicrobial prophylaxis in surgery: mechanisms, misconceptions, and mischief. Infect Control Hosp Epidemiol. 1993;14: 99-106.
27. Maki DG, Bohn MJ, Stolz SM, et al. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations: a double-blind randomized trial. J Thorac Cardiovasc Surg. 1992;104:1423-1434.
28. Boxma H, Broekhuizen T, Patka P, et al. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet. 1996;347:1133-1137.